{"id":"W2982150584","doi":"10.1002/cam4.2603","title":"Real‐world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non‐small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Public Health Ontario; Institut universitaire de cardiologie et de pneumologie de Québec; AstraZeneca (Canada); Université Laval; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Cancer Society Research Institute; University Health Network; University of Toronto; AstraZeneca Canada; AstraZeneca","keywords":"Gefitinib; Medicine; Internal medicine; Osimertinib; Lung cancer; Epidermal growth factor receptor; Oncology; Rash; Chemotherapy; Cohort; Tyrosine-kinase inhibitor; Performance status; Erlotinib; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001912357,0.0003875637,0.0009209685,0.0004151656,0.00009872214,0.00001331252,0.00009851511,0.00008271162,0.001147462],"category_scores_gemma":[0.00006901476,0.0002988953,0.00005784443,0.0007693471,0.0001404091,0.0001476487,0.00005642049,0.0002977172,0.00001046289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00119004,"about_ca_system_score_gemma":0.0009283625,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02419571,"about_ca_topic_score_gemma":0.008699297,"domain_scores_codex":[0.9976258,0.00006676874,0.0006539973,0.0006914258,0.0003395242,0.0006225455],"domain_scores_gemma":[0.9985011,0.0001287218,0.0002137139,0.0003490708,0.0002129292,0.0005944299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006822912,0.0002005695,0.9245496,0.00177757,0.0001275454,0.00003470086,0.009551358,0.00007138583,0.01952614,0.00003583522,0.01323008,0.03021292],"study_design_scores_gemma":[0.01484428,0.001515526,0.9361641,0.006519431,0.0002729233,0.000005352533,0.002027407,0.0004420546,0.02870945,0.00002664622,0.008910194,0.0005626464],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9623625,0.01617358,0.00002982426,0.01587632,0.00123889,0.002475165,0.0002432748,0.00008441171,0.001516045],"genre_scores_gemma":[0.9843772,0.00579354,0.0004295009,0.003883189,0.0004820489,0.0004758955,0.0001359893,0.00006255967,0.004360097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02965027,"threshold_uncertainty_score":0.9999463,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01690395679656957,"score_gpt":0.3392901433306463,"score_spread":0.3223861865340767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}